Mindfulness-Oriented Recovery Enhancement For Chronic Pain and Prescription Opioid Misuse in Primary Care
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Pain
- Sponsor
- University of Utah
- Enrollment
- 250
- Locations
- 1
- Primary Endpoint
- Change in opioid misuse
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
The central aim of this study is to test the efficacy of Mindfulness-Oriented Recovery Enhancement (MORE), an intervention designed to disrupt the risk chain leading from chronic pain to prescription opioid misuse and addiction. The investigators plan to conduct a full scale clinical trial to determine whether MORE (relative to a support group control condition) can reduce symptoms of chronic pain and opioid misuse among patients who are receiving pain management in primary care via long-term opioid analgesic therapy.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age 18-60+
- •Current back pain diagnosis as determined from ICD-9 codes in claims data (including but not limited to ICD-9 diagnoses 724.x, or 847.x) or current chronic pain diagnosis determined by physician assessment (including but not limited to ICD-9 diagnoses 338.0, 338.21, 338.22, 338.28, 338.29, 338.4)
- •Current use of prescription opioid agonist or mixed agonist-antagonist analgesics for \>90 days, and evidence of opioid misuse as indicated by the Current Opioid Misuse Measure
- •Willingness to participate in study interventions and assessments
Exclusion Criteria
- •Prior experience with Mindfulness-Based Stress Reduction, Mindfulness-Based Cognitive Therapy, or Mindfulness-Based Relapse Prevention
- •Active suicidality, schizophrenia, psychotic disorder, and/or substance dependence (other than opioid dependence)
- •Presence of clinically unstable systemic illness judged to interfere with treatment
Outcomes
Primary Outcomes
Change in opioid misuse
Time Frame: Change from baseline through study completion (9 months post-treatment)
Opioid misuse as evidenced by triangulated aggregate of Current Opioid Misuse Measure and/or clinician assessment via Addiction Behaviors Checklist and/or urine screen
Change in pain severity and interference
Time Frame: Change from baseline through study completion (9 months post-treatment)
Brief Pain Inventory
Secondary Outcomes
- Change in psychological distress(Change from baseline through study completion (9 months post-treatment))
- Change in opioid dose(Change from baseline through study completion (9 months post-treatment))
- Change in opioid craving(Change from baseline through study completion (9 months post-treatment))